177 related articles for article (PubMed ID: 12680157)
21. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
22. [Medical management of malignant gliomas].
Béhin A; Delattre JY
Cancer Radiother; 2000 Nov; 4 Suppl 1():67s-83s. PubMed ID: 11194966
[TBL] [Abstract][Full Text] [Related]
23. Oral topotecan in children with recurrent or progressive high-grade glioma: a Phase I/II study by the German Society for Pediatric Oncology and Hematology.
Wagner S; Erdlenbruch B; Längler A; Gnekow A; Kühl J; Albani M; Völpel S; Bucsky P; Emser A; Peters O; Wolff JE
Cancer; 2004 Apr; 100(8):1750-7. PubMed ID: 15073866
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.
Narayana A; Yamada J; Berry S; Shah P; Hunt M; Gutin PH; Leibel SA
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):892-7. PubMed ID: 16458777
[TBL] [Abstract][Full Text] [Related]
26. [Concentration of ACNU in a branch of middle cerebral artery, femoral vein and brain tissue by intracarotid or intravenous administration in a patient with recurrent glioblastoma].
Nakagawa H; Murasawa A; Nakajima S; Furuta Y; Nakajima Y
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2667-9. PubMed ID: 2774595
[No Abstract] [Full Text] [Related]
27. Hypothyroidism promotes survival.
Garfield D
Lancet Oncol; 2002 Jun; 3(6):328. PubMed ID: 12107013
[No Abstract] [Full Text] [Related]
28. Irinotecan therapy in adults with recurrent or progressive malignant glioma.
Friedman HS; Petros WP; Friedman AH; Schaaf LJ; Kerby T; Lawyer J; Parry M; Houghton PJ; Lovell S; Rasheed K; Cloughsey T; Stewart ES; Colvin OM; Provenzale JM; McLendon RE; Bigner DD; Cokgor I; Haglund M; Rich J; Ashley D; Malczyn J; Elfring GL; Miller LL
J Clin Oncol; 1999 May; 17(5):1516-25. PubMed ID: 10334539
[TBL] [Abstract][Full Text] [Related]
29. A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas.
Odia Y; Kreisl TN; Aregawi D; Innis EK; Fine HA
J Neurooncol; 2015 Oct; 125(1):191-5. PubMed ID: 26285768
[TBL] [Abstract][Full Text] [Related]
30. Chemotherapy for high-grade gliomas.
Galanis E; Buckner J
Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
[No Abstract] [Full Text] [Related]
31. Neonatal thyroid enlargement associated with propylthiouracil therapy of Graves' disease during pregnancy: a problem revisited.
Gallagher MP; Schachner HC; Levine LS; Fisher DA; Berdon WE; Oberfield SE
J Pediatr; 2001 Dec; 139(6):896-900. PubMed ID: 11743522
[No Abstract] [Full Text] [Related]
32. Combination carmustine (BCNU) and dianhydrogalactitol in the treatment of primary brain tumors recurring after irradiation.
Eagan RT; Dinapoli RP; Hermann RC; Groover RV; Layton DD; Scott M
Cancer Treat Rep; 1982 Aug; 66(8):1647-9. PubMed ID: 7105055
[No Abstract] [Full Text] [Related]
33. Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I/II study.
Yung WK; Prados M; Levin VA; Fetell MR; Bennett J; Mahaley MS; Salcman M; Etcubanas E
J Clin Oncol; 1991 Nov; 9(11):1945-9. PubMed ID: 1658242
[TBL] [Abstract][Full Text] [Related]
34. Recurrent psammocarcinoma of the peritoneum with complete response to tamoxifen therapy.
Molpus KL; Wu H; Fuller AF
Gynecol Oncol; 1998 Feb; 68(2):206-9. PubMed ID: 9514798
[TBL] [Abstract][Full Text] [Related]
35. Relationship between Ki-67 labeling index and survival in high-grade glioma patients treated after surgery with tamoxifen.
Mastronardi L; Guiducci A; Puzzilli F; Ruggeri A
J Neurosurg Sci; 1999 Dec; 43(4):263-70. PubMed ID: 10864388
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
[TBL] [Abstract][Full Text] [Related]
37. Prolonged drug treatment of hyperthyroidism.
Burrows BA; Slingerland DW
Trans Am Clin Climatol Assoc; 1977; 88():219-26. PubMed ID: 70878
[No Abstract] [Full Text] [Related]
38. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen.
Couldwell WT; Weiss MH; DeGiorgio CM; Weiner LP; Hinton DR; Ehresmann GR; Conti PS; Apuzzo ML
Neurosurgery; 1993 Mar; 32(3):485-9; discussion 489-90. PubMed ID: 8384328
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen as a potential treatment of glioma.
Mastronardi L; Puzzilli F; Ruggeri A
Anticancer Drugs; 1998 Aug; 9(7):581-6. PubMed ID: 9773800
[TBL] [Abstract][Full Text] [Related]
40. Hyperthyroidism after hypothyroidism.
Al-Sharafi BA; Khardori R
South Med J; 2000 Jul; 93(7):703-7. PubMed ID: 10923960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
